University Of Utah Obstetrics & Gynecology 50 N Medical Dr, Salt Lake City, UT 84132 8015817647 (phone)
Intermountain Medical GroupMckay-Dee Hospital Center For Maternal Fetal Medicine 4401 Harrison Blvd STE 4600, Ogden, UT 84403 8013874647 (phone), 8013874657 (fax)
University Hospital Maternal Fetal Medicine 50 N Medical Dr, Salt Lake City, UT 84132 8015818425 (phone), 8015852594 (fax)
Education:
Medical School University of Utah School of Medicine Graduated: 1992
Procedures:
Cesarean Section (C-Section) Vaginal Delivery
Conditions:
Complicating Pregnancy or Childbirth Conditions of Pregnancy and Delivery Pregnancy-Induced Hypertension Uncomplicated or Low Risk Pregnancy and Delivery Abnormal Vaginal Bleeding
Languages:
English Spanish
Description:
Dr. Draper graduated from the University of Utah School of Medicine in 1992. He works in Ogden, UT and 2 other locations and specializes in Obstetrics & Gynecology. Dr. Draper is affiliated with Intermountain McKay-Dee Hospital Center, Logan Regional Hospital and University Of Utah Hospital.
Michael W. Draper - Carmel IN, US Larry J. Black - Franklin IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A01N 43/12
US Classification:
514443
Abstract:
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompassed by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Larry J. Black - Indianapolis IN George J. Cullinan - Trafalgar IN Michael W. Draper - Carmel IN Charles D. Jones - Indianapolis IN David E. Seyler - Greenfield IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445 A61K 3140 A61K 3138
US Classification:
514324
Abstract:
A method of inhibiting uterine fibrosis comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R. sup. 1 and R. sup. 3 are independently hydrogen, ##STR2## wherein Ar is optionally substituted phenyl; wherein R. sup. 2 is selected from the group consisting of pyrrolidino and piperidino, a pharmaceutically acceptable salt or solvate thereof.
Larry J. Black - Indianapolis IN George J. Cullinan - Trafalgar IN Michael W. Draper - Carmel IN Charles D. Jones - Indianapolis IN David E. Seyler - Greenfield IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445 A61K 3140 A61K 3138
US Classification:
514324
Abstract:
A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R. sup. 1 and R. sup. 3 are independently hydrogen, --CH. sub. 3, ##STR2## wherein Ar is optionally substituted phenyl; R. sup. 2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Methods Of Use For Inhibiting Bone Loss And Lowering Serum Cholesterol
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Larry J. Black - Indianapolis IN George J. Cullinan - Trafalgar IN Michael W. Draper - Carmel IN Charles D. Jones - Indianapolis IN David E. Seyler - Greenfield IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445 A61K 3140 A61K 3138
US Classification:
514324
Abstract:
A method of inhibiting endometriosis comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## Wherein R. sup. 1 and R. sup. 3 are independently hydrogen, --CH. sub. 3, ##STR2## wherein Ar is optionally substituted phenyl; R. sup. 2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Methods Of Use For Inhibiting Bone Loss And Lowering Serum Cholesterol
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Methods Of Use For Inhibiting Bone Loss And Lowering Serum Cholesterol
A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.